Journal article

Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study

Abstract:: Background
In Nepal, Streptococcus pneumoniae (pneumococcus) is a common cause of bacterial pneumonia in children, and is a major health concern. There are few data on the effect of vaccination on the disease or colonisation with pneumococci in the nasopharynx of children in this setting. The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced into the routine infant immunisation schedule in Nepal in 2015. We aimed to investigate the effect of the introduc... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Shrestha, S., Gurung, M., Amatya, P., Bijukchhe, S., Bose, A., Carter, M., Gautam, M., Gurung, S., Hinds, J., Kandasamy, R., Kelly, S., Khadka, B., Maskey, P., Mujadidi, Y., O’Reilly, P., Pokhrel, B., Pradhan, R., Shah, G., Shrestha, S., … Pollard, A. (2022). Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study. The Lancet Global Health, 10(10), e1494–e1504.

MLA Style

Shrestha, S., et al. “Effect of the of 10-Valent Pneumococcal Conjugate Vaccine in Nepal 4 Years after Introduction: An Observational Cohort Study.” The Lancet Global Health, vol. 10, no. 10, 2022, pp. e1494–504.

Chicago Style

Shrestha, S., M. Gurung, P. Amatya, et al. 2022. “Effect of the of 10-Valent Pneumococcal Conjugate Vaccine in Nepal 4 Years after Introduction: An Observational Cohort Study.” The Lancet Global Health 10 (10): e1494–504.
Print

Access Document

Files:: Shrestha_et_al_2022_10-_alent_pneumococcal.pdf

(Preview, Version of record, pdf, 865.9KB, Terms of use)

Shrestha_et_al_2022_Supplementary.pdf

(Preview, Supplementary materials, pdf, 741.5KB, Terms of use)

Publisher copy:: 10.1016/s2214-109x(22)00281-9

Authors

+ Shrestha, S More by this author

Role:: Author

+ Gurung, M More by this author

Role:: Author

+ Amatya, P More by this author

Role:: Author

+ Bijukchhe, S More by this author

Role:: Author

+ Bose, AS More by this author

Role:: Author

More authors...

Contributors

+ PneumoNepal study group

Role:: Contributor

Publisher:: Elsevier
Journal:: The Lancet Global Health More from this journal
Volume:: 10
Issue:: 10
Pages:: e1494-e1504
Publication date:: 2022-09-13
Acceptance date:: 2022-05-30
DOI:: 10.1016/s2214-109x(22)00281-9
EISSN:: 2214-109X
ISSN:: 2214-109X

Language:: English
Keywords:: FFR
Pubs id:: 1278883
UUID:: uuid_ebf0eb3b-d27e-4cd7-b10a-c28a98a94219
Local pid:: pubs:1278883
Deposit date:: 2022-09-15
ARK identifier:: ark:/29072/ora_ebf0eb3bd27e4cd7b10ac28a98a94219

Terms of use

Copyright holder:: Shrestha et al.
Copyright date:: 2022
Rights statement:: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Licence:: CC Attribution (CC BY)

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP